Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Get Free Report) has earned an average recommendation of "Moderate Buy" from the twelve analysts that are covering the stock, Marketbeat.com reports. One...